Comparative Evaluation of Commercial Test Kits Cleared for Use in Modified Two-Tiered Testing Algorithms for Serodiagnosis of Lyme Disease
The Journal of Infectious Diseases · 2024
DOI: 10.1093/infdis/jiae229 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift The Journal of Infectious Diseases, 2024. Verfasst von Elizabeth L Lewandrowski und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA. Hauptthemen laut MEDLINE: Lyme Disease, Serologic Tests, Immunoglobulin G, Immunoglobulin M. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 19 Literaturangaben. Gefördert von: Zeus Scientific.
Abstract (Originalsprache)
Background
Modified 2-tiered testing (MTTT) for Lyme disease utilizes automatable, high throughput immunoassays (AHTIs) in both tiers without involving western immunoblots, offering performance and practical advantages over standard 2-tiered testing (STTT; first-tier AHTI followed by immunoglobulin M (IgM) and immunoglobulin G (IgG) western immunoblots). For MTTT, Centers for Disease Control and Prevention recommends using AHTI test kits that have been cleared by Food and Drug Administration (FDA) specifically for this intended use. We evaluated performance of FDA-cleared MTTT commercial test kits from 3 manufacturers by comparing with STTT results.
Methods
We performed MTTT (total antibody AHTI with reflex to separate IgM and IgG AHTIs) using test kits from Diasorin, Gold Standard Diagnostics (GSD), and Zeus Scientific on 382 excess serum samples submitted to the clinical laboratory for routine Lyme disease serologic testing in July 2018, measuring agreement between MTTT and STTT using the κ statistic.
Results
Overall agreement with STTT was 0.87 (95% confidence interval [CI], .77–.97) using Diasorin assays (almost perfect agreement), 0.80 (95% CI, .68–.93) using GSD assays (substantial agreement) and 0.79 (95% CI, .68–.90) using Zeus assays (substantial agreement). For detection of IgM reactivity, agreement between MTTT and STTT was 0.70 (.51–.90; substantial), 0.63 (95% CI, .44–.82; substantial) and 0.56 (95% CI, .38–.73; moderate), respectively. For detection of IgG reactivity, MTTT/STTT agreement was 0.73 (95% CI,.58–.88), 0.78 (95% CI, .62–.94), and 0.75 (95% CI, .60–.90), respectively (substantial agreement in all cases).
Conclusions
MTTT results obtained using commercial test kits from 3 different manufacturers had substantial to almost perfect agreement with STTT results overall and moderate to substantial agreement for IgM and IgG detection independently. Commercial MTTT tests can be used broadly for the diagnosis of Lyme disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA.
- Division of Infectious Diseases, Massachusetts General Hospital, Boston, Massachusetts, USA.
- Division of Emergency Medicine, Boston Children's Hospital, Boston, Massachusetts, USA.
- Department of Pediatrics, Boston Children's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
ORCID-Profile: Sarah E Turbett
Förderung
- Zeus Scientific
Zitieren
APA
Lewandrowski, E. L., Turbett, S. E., Nigrovic, L. E., Klontz, E. H., & Branda, J. A. (2024). Comparative Evaluation of Commercial Test Kits Cleared for Use in Modified Two-Tiered Testing Algorithms for Serodiagnosis of Lyme Disease. The Journal of Infectious Diseases. https://doi.org/10.1093/infdis/jiae229
Vancouver
Lewandrowski EL, Turbett SE, Nigrovic LE, Klontz EH, Branda JA. Comparative Evaluation of Commercial Test Kits Cleared for Use in Modified Two-Tiered Testing Algorithms for Serodiagnosis of Lyme Disease. The Journal of Infectious Diseases. 2024. doi:10.1093/infdis/jiae229
BibTeX
@article{Lewandrowski2024,
author = {Lewandrowski, Elizabeth L and Turbett, Sarah E and Nigrovic, Lise E and Klontz, Erik H and Branda, John A},
title = {Comparative Evaluation of Commercial Test Kits Cleared for Use in Modified Two-Tiered Testing Algorithms for Serodiagnosis of Lyme Disease},
journal = {The Journal of Infectious Diseases},
year = {2024},
doi = {10.1093/infdis/jiae229}
}
EUVIMED